Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-07-12
2011-07-12
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S398000, C514S387000, C548S255000, C548S302700, C548S335500, C544S235000
Reexamination Certificate
active
07977334
ABSTRACT:
The present invention relates to new beta-agonists of general formula (I)wherein the groups R1to R7have the meanings given in the claims and specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, processes for preparing these compounds and their use as pharmaceutical compositions.
REFERENCES:
patent: 2943090 (1960-06-01), Semb et al.
patent: 3092636 (1963-06-01), Heinzelman et al.
patent: 4154829 (1979-05-01), Mentrup et al.
patent: 4215119 (1980-07-01), Mentrup et al.
patent: 4363814 (1982-12-01), Mentrup et al.
patent: 4478849 (1984-10-01), Ainsworth
patent: 4647563 (1987-03-01), Schromm et al.
patent: 6667342 (2003-12-01), Clarke et al.
patent: 7214698 (2007-05-01), Trieselmann et al.
patent: 2003/0191174 (2003-10-01), Ikuta et al.
patent: 2004/0127733 (2004-07-01), Trieselmann et al.
patent: 2005/0020602 (2005-01-01), Miyoshi et al.
patent: 2005/0245526 (2005-11-01), Trieselmann et al.
patent: 2007/0105906 (2007-05-01), Walter et al.
patent: 2007/0112033 (2007-05-01), Trieselmann et al.
patent: 2008/0103138 (2008-05-01), Trieselmann et al.
patent: 2008/0269281 (2008-10-01), Trieselmann et al.
patent: 2008/0300290 (2008-12-01), Walter et al.
patent: 2504213 (2004-05-01), None
patent: 2564980 (2005-11-01), None
patent: 2115926 (1972-10-01), None
patent: 0008653 (1980-03-01), None
patent: 0177245 (1986-04-01), None
patent: 0659737 (1995-06-01), None
patent: 1277736 (2003-01-01), None
patent: 1447400 (2004-08-01), None
patent: 1200886 (1970-08-01), None
patent: 2356197 (2001-05-01), None
patent: 9529159 (1995-11-01), None
patent: 9721665 (1997-06-01), None
patent: 0040560 (2000-07-01), None
patent: 0162705 (2001-08-01), None
patent: 0183452 (2001-11-01), None
patent: 0200622 (2002-01-01), None
patent: 0206281 (2002-01-01), None
patent: 03072572 (2003-09-01), None
patent: 2004-39784 (2004-05-01), None
patent: 2005108373 (2005-11-01), None
Arch; B3-Andrenoceptor agonists: potential, pitfalls and progress; European Journal of Pharmacology; 2002; vol. 440; pp. 99-107.
Clifton et al.; Arylethanolamines derived from salicylamide with .alpha.- and .beta.-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers and related salicylamides; Journal of Medicinal Chemistry; 1982; vol. 25; No. 6; pp. 670-679.
Kawashima Kazu; Publication No. 08165276; Publication Date Jun. 25, 1996; 2-akylamino-1-phenylethanol derivative; Patent Abstracts of Japan; vol. 1996; No. 10.
Harada et al.; Discovery of a Novel and Potent Human and Rat B3-Adrenergic Receptor Agonist, [3-[(2R)-[[(2R)-(3Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1H-indol-7-yloxy]acetic Acid; Chemical & Pharmaceutical Bulletin; Feb. 2005; vol. 53; No. 2; pp. 184-198.
Moffett; New compounds with possible pharmacological activity; Journal of Chemical and Engineering Data; 1980; vol. 25; No. 2; pp. 176-183.
Thompson et al.; Protein Conformational Misfolding and Amyloid Formation: Characteristics of a New Class of Disorders that Include Alzheimer's and Prion Diseases; Current Medicinal Chemistry; 2002; vol. 9; pp. 1751-1762.
International Search Report, Form PCT/ISA/210, for corresponding PCT/EP2006/067868; mailed on Jan. 9, 2007.
International Search Report, Form PCT/ISA/210, for corresponding PCT/EP2006/067874; mailed on Jan. 5, 2007.
International Search Report, Form PCT/ISA/210, for corresponding PCT/EP2006/067875; mailed on Mar. 30, 2007.
International Search Report for PCT/EP2005/004385 mailed on Sep. 15, 2005.
Hamilton Bradford S.
Trieselmann Thomas
Boehringer Ingelheim International GmbH
Lazer Edward S.
Morris Michael P.
Shiao Rei-tsang
LandOfFree
Beta-agonists, methods for the preparation thereof and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-agonists, methods for the preparation thereof and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-agonists, methods for the preparation thereof and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2694435